These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28320414)

  • 1. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
    Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
    J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors.
    Olasz J; Mándoky L; Géczi L; Bodrogi I; Csuka O; Bak M
    Anticancer Res; 2005; 25(6B):4319-24. PubMed ID: 16309235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
    Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
    Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
    Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
    World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of microsatellite instability and BRAF (V600E) mutation in testicular germ cell tumors.
    Cárcano FM; Lengert AH; Vidal DO; Scapulatempo Neto C; Queiroz L; Marques H; Baltazar F; Berardinelli GN; Martinelli CM; da Silva EC; Reis RM; Lopes LF
    Andrology; 2016 Sep; 4(5):866-72. PubMed ID: 27153176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
    Olofsson SE; Nodin B; Gaber A; Eberhard J; Uhlén M; Jirström K; Jerkeman M
    PLoS One; 2015; 10(3):e0121300. PubMed ID: 25811459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of patients with stage II and III nonseminomatous germ cell tumors: results of a single center.
    Ataergin S; Ozet A; Arpaci F; Kilic S; Beyzadeoglu M; Komurcu S
    Indian J Cancer; 2007; 44(1):6-11. PubMed ID: 17401218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mononucleotide markers of microsatellite instability in carcinomas of the urinary bladder.
    Saetta AA; Goudopoulou A; Korkolopoulou P; Voutsinas G; Thomas-Tsagli E; Michalopoulos NV; Patsouris E
    Eur J Surg Oncol; 2004 Sep; 30(7):796-803. PubMed ID: 15296997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma.
    Gilbert DC; Al-Saadi R; Thway K; Chandler I; Berney D; Gabe R; Stenning SP; Sweet J; Huddart R; Shipley JM
    Clin Cancer Res; 2016 Mar; 22(5):1265-73. PubMed ID: 26453693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective mismatch repair and the development of recurrent endometrial carcinoma.
    Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
    Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
    Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
    Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas.
    Lobo J; Stoop H; Gillis AJM; Looijenga LHJ; Oosterhuis W
    Am J Surg Pathol; 2019 Dec; 43(12):1711-1719. PubMed ID: 31490238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents.
    Gilbert DC; Chandler I; McIntyre A; Goddard NC; Gabe R; Huddart RA; Shipley J
    J Pathol; 2009 Jan; 217(1):94-102. PubMed ID: 18839394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?
    Scandura G; Wagner T; Beltran L; Alifrangis C; Shamash J; Berney DM
    Mod Pathol; 2021 Apr; 34(4):834-841. PubMed ID: 33319858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rete Testis Invasion Is Consistent With Pathologic Stage T1 in Germ Cell Tumors.
    Farooq A; Jorda M; Whittington E; Kryvenko ON; Braunhut BL; Pavan N; Procházková K; Zhang L; Rai S; Miller T; Liu J; Szabo A; Iczkowski KA
    Am J Clin Pathol; 2019 Apr; 151(5):479-485. PubMed ID: 30576407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachyury oncogene is a prognostic factor in high-risk testicular germ cell tumors.
    Pinto F; Cárcano FM; da Silva ECA; Vidal DO; Scapulatempo-Neto C; Lopes LF; Reis RM
    Andrology; 2018 Jul; 6(4):597-604. PubMed ID: 29749711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
    Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
    Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.
    Sinicrope FA; Rego RL; Halling KC; Foster N; Sargent DJ; La Plant B; French AJ; Laurie JA; Goldberg RM; Thibodeau SN; Witzig TE
    Gastroenterology; 2006 Sep; 131(3):729-37. PubMed ID: 16952542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
    Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
    Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.